TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancer

Stefan Steurer, Pascale Sophia Mayer, Meike Adam, Antje Krohn, Christina Koop, Daniel Ospina-Klinck, Ali Attarchi Tehrani, Ronald Simon, Pierre Tennstedt, Markus Graefen, Corinna Wittmer, Benedikt Brors, Christoph Plass, Jan Korbel, Joachim Weischenfeldt, Guido Sauter, Hartwig Huland, Maria Christina Tsourlakis, Sarah Minner, Thorsten Schlomm